Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.
Department of Surgery, Minimally Invasive Surgery Research Center, Division of Minimally Invasive and Bariatric Surgery, Rasool-E Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Surg Endosc. 2024 Feb;38(2):888-893. doi: 10.1007/s00464-023-10578-w. Epub 2023 Dec 11.
Helicobacter pylori (HP) is the most common human infection that has affected up to 50% of the population worldwide. The relationship between HP eradication and weight loss is under debate. The present study aimed to compare weight loss outcomes after Roux-en-Y gastric bypass (RYGB) in HP-negative (HP-) and HP-eradicated (HPe) patients during five years follow-ups.
This retrospective cohort study was conducted on 305 patients aged 18 and more with severe obesity, who underwent primary RYGB from February 2014 to November 2017. The HP-negative and HP-eradicated patients were evaluated for weight loss outcomes during five years follow-ups.
Patients' mean age, mean weight, and mean body mass index were 38.78 ± 9.9, 114.8 ± 13.6, and 43.37 ± 2.55, respectively. 27.2% of patients who were HP-positive were treated before RYGB. There was no significant difference between the HP- and HPe patients in terms of total weight loss percent (%TWL), 12 to 60 months after RYGB. Excess weight loss percent (%EWL) was higher in HPe patients compared to HP- patients (P = 0.04) at 12-month after RYGB. However, there was no difference in %EWL between these two groups of patients, 36 and 60 months after RYGB.
The results of the present study showed that TWL% had no significant difference in HP- and HPe groups during five years follow-ups after RYGB. The %EWL was higher in HPe patients only at 12 months after RYGB and the difference did not persist over time.
幽门螺杆菌(HP)是最常见的人类感染,全球有多达 50%的人口受到影响。HP 根除与体重减轻之间的关系存在争议。本研究旨在比较 Roux-en-Y 胃旁路术(RYGB)后五年随访中 HP 阴性(HP-)和 HP 根除(HPe)患者的体重减轻结果。
这项回顾性队列研究纳入了 2014 年 2 月至 2017 年 11 月期间因严重肥胖而接受初次 RYGB 的 305 名年龄在 18 岁及以上的患者。评估了 HP-和 HPe 患者在五年随访期间的体重减轻结果。
患者的平均年龄、平均体重和平均体重指数分别为 38.78±9.9、114.8±13.6 和 43.37±2.55。27.2%的 HP 阳性患者在 RYGB 前接受了治疗。HP-和 HPe 患者在 RYGB 后 12 至 60 个月的总体重减轻百分比(%TWL)方面无显著差异。与 HP-患者相比,HPe 患者在 RYGB 后 12 个月时的超重减轻百分比(%EWL)更高(P=0.04)。然而,在 RYGB 后 36 和 60 个月时,两组患者的%EWL 无差异。
本研究结果表明,在 RYGB 后五年随访期间,HP-和 HPe 组的 TWL% 无显著差异。仅在 RYGB 后 12 个月时,HPe 患者的%EWL 更高,而且这种差异随着时间的推移而消失。